Announcements
28 May 2025
Meet Us at the 47th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 14–18 July 2025, Copenhagen, Denmark
30 April 2025
Richard DiMarchi and Rolf Müller Share the 2024 Tu Youyou Award
We are pleased to announce that the 2024 Tu Youyou Award has been conferred upon Richard DiMarchi and Rolf Müller, in recognition of their significant contributions to natural products chemistry and medicinal chemistry.
 Richard DiMarchi Indiana University, USA |
Prof. Richard DiMarchi is a Distinguished Professor of Chemistry and Gill Chair in Biomolecular Sciences at Indiana University, USA. He is a member of the National Academy of Medicine and the National Inventors Hall of Fame. Dr. DiMarchi is a former Group Vice President at Eli Lilly and later at Novo Nordisk. He is recognized for his contributions to the discovery and development of rDNA-derived Humulin®, Humalog®, rGlucagon®, and Forteo®. His academic research has broadened the understanding of glucagon and incretin physiology and pioneered the discovery of single-molecule multi-mechanism agonists for the treatment of diabetes and obesity. The central element to success has been the chemical vision and technology to install within single molecules simultaneous agonism at related G-protein coupled receptors, coupled to the counter-intuitive discovery that glucagon and GIP agonism could synergize the therapeutic efficacy of GLP-1. These peptides and their conceptual approach have transformed the management of excessive body weight to a condition comparable to how hypertension, adult-onset diabetes, and excess cholesterol are medicinally managed. |
| “Professor DiMarchi was recognized by the 2024 Tu Youyou Award Committee members as being an exceptional leader in the medicinal chemistry of peptides and proteins of natural origin, and as a pioneer in the field of chemical biotechnology. His very important discoveries have led to breakthroughs in new drugs related to the therapy of diabetes and obesity. He has been named as an inventor on a very large number of patents, and he has had initially a highly successful scientific and administrative career in industry, which was followed by over two decades in academia as a distinguished professor.” —Prof. Dr. A. Douglas Kinghorn, Chair of the Award Committee |
|
 Rolf Müller Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Germany; Helmholtz Centre for Infections Research (HZI), Germany; Saarland University, Germany |
Prof. Rolf Müller is the Founding and Managing Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Professor of Pharmaceutical Biotechnology at Saarland University, Germany. Having received his training from the University of Bonn, he held research positions at the University of Washington, USA, and Braunschweig University of Technology, Germany, prior to his appointment as professor to Saarland University. His laboratory has dedicated itself to the exploration of bacterial natural-product biosynthetic pathways for more than 20 years and has extensive experience in working with myxobacteria and other microbial producer strains. Starting from the isolation and characterization of new microorganisms, the scope of work includes microbiology-, biotechnology-, bioinformatics-, and chemistry-based approaches to exploit these isolates as sources of new drugs with a special focus on novel anti-infectives. Müller and his team apply a variety of state-of-the-art analytical methods and biological assays to perform biological and chemical characterizations of the identified compounds. Prof. Müller has received several awards, including the prestigious Gottfried Wilhelm Leibniz Prize, the PHOENIX Pharmacy Research Award, the DECHEMA Prize, and the Inhoffen Medal, as well as being an elected member of acatech, Leopoldina, and the German Academy of Sciences and Literature. |
| “The 2024 Tu Youyou Award Committee members were highly impressed by the truly outstanding past and ongoing contributions of Professor Müller in both microbial natural products isolation chemistry and in biosynthesis, as well as in the development of lead compounds for their potential in treating human diseases, through his global connections with various major funding agencies. He is also a dedicated teacher who has trained numerous graduate students and postdoctoral fellows, and he has lectured on his research in countries all over the world.” —Prof. Dr. A. Douglas Kinghorn, Chair of the Award Committee |
|
The achievements of Richard DiMarchi and Rolf Müller highlight the transformative impact of natural products chemistry and medicinal chemistry. We congratulate them and invite the global academic community and public to join us in celebrating their significant contributions.
2024 Award Committee
Committee Chair:
- Prof. Dr. A. Douglas Kinghorn, Ohio State University, USA.
Committee Members (listed in alphabetical order):
- Prof. Angelo Fontana, University of Naples “Federico II”, Italy;
- Prof. Binghe Wang, Georgia State University, USA;
- Dr. Diana Pinto, University of Aveiro, Portugal;
- Prof. Hideaki Kakeya, Kyoto University, Japan;
- Dr. RuAngelie Edrada-Ebel, University of Strathclyde, UK;
- Prof. Thomas Prisinzano, University of Kentucky, USA
- Prof. Wei Li, University of Tennessee Health Science Center, USA.
About the Tu Youyou Award:
The 2024 Tu Youyou Award includes a total monetary prize of 100,000 Swiss Francs and a medal for each recipient. Established in 2016 to honor the pioneering spirit of Nobel laureate Tu Youyou, the Tu Youyou Award is an international award honoring exceptional scholars dedicated to the fields of natural products chemistry and medicinal chemistry.
For further information about the award and the winners, please visit the Tu Youyou Award website.
30 June 2025
Journal of Clinical Medicine | Selected Feature Papers Published in 2024
25 June 2025
Journal of Clinical Medicine | Highly Cited Papers and Hot Topic Special Issues on Asthma
The complexity of asthma as a chronic respiratory disease makes achieving a cure challenging, but medical researchers are continuously exploring new avenues for treatment. We invite you to explore the esteemed collection of highly cited articles on asthma that have been published in Journal of Clinical Medicine (JCM, ISSN: 2077-0383) over the past two years, and we hope that they can provide you with new insights. We are currently accepting submissions for Special Issues focusing on asthma, and we look forward to your contributions.
1. “A Real-World Study of Achievement Rate and Predictive Factors of Clinical and Deep Remission to Biologics in Patients with Severe Asthma”
by Keiji Oishi, Kazuki Hamada, Yoriyuki Murata, Kazuki Matsuda, Syuichiro Ohata, Yoshikazu Yamaji, Maki Asami-Noyama, Nobutaka Edakuni, Tomoyuki Kakugawa, Tsunahiko Hirano et al.
J. Clin. Med. 2023, 12(8), 2900; https://doi.org/10.3390/jcm12082900
Full text available online: https://www.mdpi.com/2077-0383/12/8/2900
2. “Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis”
by Corrado Pelaia, Giulia Pelaia, Angelantonio Maglio, Caterina Tinello, Luca Gallelli, Nicola Lombardo, Rosa Terracciano and Alessandro Vatrella
J. Clin. Med. 2023, 12(10), 3371; https://doi.org/10.3390/jcm12103371
Full text available online: https://www.mdpi.com/2077-0383/12/10/3371
3. “Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study”
by Laura Diego Bagnasco Pini, Bianca Beghè, Fulvio Braido, Paolo Cameli, Marco Caminati, Cristiano Caruso, Claudia Crimi, Gabriella Guarnieri, Manuela Latorre et al.
J. Clin. Med. 2024, 13(10), 3013; https://doi.org/10.3390/jcm13103013
Full text available online: https://www.mdpi.com/2077-0383/13/10/3013
4. “Severe Asthma and Biological Therapies: Now and the Future”
by Olaia Sardon-Prado, Carolina Diaz-Garcia, Paula Corcuera-Elosegui, Javier Korta-Murua, Jose Valverde-Molina and Manuel Sanchez-Solis
J. Clin. Med. 2023, 12(18), 5846; https://doi.org/10.3390/jcm12185846
Full text available online: https://www.mdpi.com/2077-0383/12/18/5846
5. “Reliability of Total Serum IgE Levels to Define Type 2 High and Low Asthma Phenotypes
by Giuseppe Guida, Francesca Bertolini, Vitina Carriero, Stefano Levra, Andrea Elio Sprio, Martina Sciolla, Giulia Orpheu, Elisa Arrigo, Stefano Pizzimenti, Giorgio Ciprandi et al.
J. Clin. Med. 2023, 12(17), 5447; https://doi.org/10.3390/jcm12175447
Full text available online: https://www.mdpi.com/2077-0383/12/17/5447
6. “Asthma Phenotypes in the Era of Personalized Medicine”
by Victor Gonzalez-Uribe, Sergio J. Romero-Tapia and Jose A. Castro-Rodriguez
J. Clin. Med. 2023, 12(19), 6207; https://doi.org/10.3390/jcm12196207
Full text available online: https://www.mdpi.com/2077-0383/12/19/6207
7. “Managing Small Airway Disease in Patients with Severe Asthma: Transitioning from the “Silent Zone” to Achieving “Quiet Asthma””
by Giovanna Elisiana Carpagnano, Andrea Portacci, Silvano Dragonieri, Francesca Montagnolo, Ilaria Iorillo, Ernesto Lulaj, Leonardo Maselli, Enrico Buonamico and Vitaliano Nicola Quaranta
J. Clin. Med. 2024, 13(8), 2320; https://doi.org/10.3390/jcm13082320
Full text available online: https://www.mdpi.com/2077-0383/13/8/2320
8. “Baseline Characteristics of Patients Enrolled in Clinical Trials of Biologics for Severe Asthma as Potential Predictors of Outcomes”
by Francesco Menzella
J. Clin. Med. 2023, 12(4), 1546; https://doi.org/10.3390/jcm12041546
Full text available online: https://www.mdpi.com/2077-0383/12/4/1546
9. “Switching to Dupilumab from Other Biologics without a Treatment Interval in Patients with Severe Asthma: A Multi-Center Retrospective Study”
by Hisao Higo, Hirohisa Ichikawa, Yukako Arakawa, Yoshihiro Mori, Junko Itano, Akihiko Taniguchi, Satoru Senoo, Goro Kimura, Yasushi Tanimoto, Kohei Miyake et al.
J. Clin. Med. 2023, 12(16), 5174; https://doi.org/10.3390/jcm12165174
Full text available online: https://www.mdpi.com/2077-0383/12/16/5174
10. “Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting”
by Carolina Vitale, Angelantonio Maglio, Corrado Pelaia, Maria D’Amato, Luigi Ciampo, Giulia Pelaia, Antonio Molino and Alessandro Vatrella
J. Clin. Med. 2023, 12(3), 985; https://doi.org/10.3390/jcm12030985
Full text available online: https://www.mdpi.com/2077-0383/12/3/985
| Special Issues | |
| “Advances in Allergic Diseases and Asthma: Clinical Insights and Emerging Therapies” Guest Editor: Prof. Dr. Zenon Brzoza Submission deadline: 20 October 2025 |
“Respiratory Medicine in the Oldest-Old” Guest Editor: Dr. Takae Ebihara Submission deadline: 25 October 2025 |
 |
 |
|
“New Clinical Advances in Pediatric Asthma” |
“Advances in Pulmonary Disease Management and Innovation in Treatment” |
 |
 |
23 June 2025
Journal of Clinical Medicine Travel Award—Open for Applications
19 June 2025
World Blood Donor Day—“Give Blood, Give Hope: Together We Save Lives”, 14 June 2025
On 14 June, the world celebrates World Blood Donor Day, a global tribute to the millions of voluntary, unpaid blood donors who give others a second chance at life. Their generosity saves lives, strengthens communities and embodies the spirit of solidarity. It is a day to say thank you, but also to spotlight the ongoing, urgent need for safe, regular blood donations.
The theme of the 2025 World Blood Donor Day is “Give blood, give hope: together we save lives” and the objectives of the campaign are to raise public awareness about the critical need for blood and plasma donations and the impact they have on patients' lives; encourage both new and existing donors to give blood regularly, helping to ensure a stable and sufficient blood supply; highlight the positive impact of blood donors on the health and well-being of others and promote the values of solidarity, compassion, and community through blood donation; and mobilize support from governments and development partners to invest in and sustain national blood programs to achieve universal access to safe blood transfusion worldwide.
In recognition of this important day, we recommend the following related articles, Special Issues, and journals spanning multidisciplinary fields, including clinical medicine. We believe that promoting such research contributes to enhanced public awareness of blood safety and selfless dedication.
 |
 |
 |
 |
“Sickle Cell Anemia and Inflammation: A Review of Stones and Landmarks Paving the Road in the Last 25 Years”
by Jessica Dorneles, Amanda de Menezes Mayer and José Artur Bogo Chies
Hematol. Rep. 2025, 17(1), 2; https://doi.org/10.3390/hematolrep17010002
“Patterns of Blood Transfusion in Sickle Cell Disease Hospitalizations”
by Aditi Sharma, Amit Dahiya, Asif Alavi, Indryas Woldie, Aditya Sharma, Jeffrey Karson and Vijendra Singh
Hemato 2024, 5(1), 26-34; https://doi.org/10.3390/hemato5010004
“Emerging Role of [18F]FLT PET/CT in Lymphoid Malignancies: A Review of Clinical Results”
by Anna Giulia Nappi, Giulia Santo, Lorenzo Jonghi-Lavarini, Alberto Miceli, Achille Lazzarato, Flavia La Torre, Francesco Dondi and Joana Gorica
Hematol. Rep. 2024, 16(1), 32-41; https://doi.org/10.3390/hematolrep16010004
“Understanding the Intricacies of Iron Overload Associated with β-Thalassemia: A Comprehensive Review”
by Subhangi Basu, Motiur Rahaman, Tuphan Kanti Dolai, Praphulla Chandra Shukla and
Nishant Chakravorty
Thalass. Rep. 2023, 13(3), 179-194; https://doi.org/10.3390/thalassrep13030017
“Bone Marrow Transplantation in Nonmalignant Haematological Diseases: What Have We Learned about Thalassemia?”
by Luca Castagna, Stefania Tringali, Giuseppe Sapienza, Roberto Bono, Rosario Di Maggio and Aurelio Maggio
Thalass. Rep. 2023, 13(2), 122-130; https://doi.org/10.3390/thalassrep13020011
“CRISPR Gene Therapy: A Promising One-Time Therapeutic Approach for Transfusion-Dependent β-Thalassemia—CRISPR-Cas9 Gene Editing for β-Thalassemia”
by Udani Gamage, Kesari Warnakulasuriya, Sonali Hansika and Gayathri N. Silva
Thalass. Rep. 2023, 13(1), 51-69; https://doi.org/10.3390/thalassrep13010006
“Cardiovascular Complications in β-Thalassemia: Getting to the Heart of It”
by Nathalie Akiki, Mohammad H. Hodroj, Rayan Bou-Fakhredin, Kamal Matli and Ali T. Taher
Thalass. Rep. 2023, 13(1), 38-50; https://doi.org/10.3390/thalassrep13010005
“Ferritin Trajectories over Repeated Whole Blood Donations: Results from the FIND+ Study”
by Sara Moazzen, Maike G. Sweegers, Mart Janssen, Boris M. Hogema, Trynke Hoekstra and Katja Van den Hurk
J. Clin. Med. 2022, 11(13), 3581; https://doi.org/10.3390/jcm11133581
“Should We Stop Collecting the Preoperative Autologous Blood before Bone Marrow Harvest?”
by Daniel Lysák, Lenka Hejretová, Marcela Hrabětová and Pavel Jindra
J. Clin. Med. 2021, 10(10), 2134; https://doi.org/10.3390/jcm10102134
|
“Anaemia in Focus: Challenges and Solutions in Haematology” |
“Modern Blood Banking and Transfusion in Clinical Practice: Second Edition” |
 |
 |
|
“Hematopathology: Rare Hematological Diseases” |
“Feature Papers in Thalassemia Reports” |
 |
 |
17 June 2025
Journal of Clinical Medicine | Highly Cited Papers in 2024 and Hot Topic Special Issues in the “Respiratory Medicine” Section
In 2025, our Section “Pulmonology” was renamed to “Respiratory Medicine”. This Section of Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is dedicated to all aspects of respiratory medicine, including the study of healthy and diseased lungs, airways, sleep medicine, and breathing. You are welcome to read the 2024 highly cited papers and find the latest publications through the following link: https://www.mdpi.com/search?journal=jcm§ion=507.
In addition, the “Respiratory Medicine” Section is accepting submissions for several Special Issues. Please find below a list of relevant articles and Special Issues:
1. “A Comprehensive Review of Risk Factors and Thrombophilia Evaluation in Venous Thromboembolism”
by Andrew B. Dicks, Elie Moussallem, Marcus Stanbro, Jay Walls, Sagar Gandhi and Bruce H. Gray
J. Clin. Med. 2024, 13(2), 362; https://doi.org/10.3390/jcm13020362
Full text available online: https://www.mdpi.com/2077-0383/13/2/362
2. “Developing a Virtual Reality Simulation System for Preoperative Planning of Robotic-Assisted Thoracic Surgery”
by Hideki Ujiie, Ryohei Chiba, Aogu Yamaguchi, Shunsuke Nomura, Haruhiko Shiiya, Aki Fujiwara-Kuroda, Kichizo Kaga, Chad Eitel, Tod R. Clapp and Tatsuya Kato
J. Clin. Med. 2024, 13(2), 611; https://doi.org/10.3390/jcm13020611
Full text available online: https://www.mdpi.com/2077-0383/13/2/611
3. “Using Artificial Intelligence to Predict Mechanical Ventilation Weaning Success in Patients with Respiratory Failure, Including Those with Acute Respiratory Distress Syndrome”
by Tamar Stivi, Dan Padawer, Noor Dirini, Akiva Nachshon, Baruch M. Batzofin and Stephane Ledot
J. Clin. Med. 2024, 13(5), 1505; https://doi.org/10.3390/jcm13051505
Full text available online: https://www.mdpi.com/2077-0383/13/5/1505
4. “Portal Vein Thrombosis: State-of-the-Art Review”
by Andrea Boccatonda, Simone Gentilini, Elisa Zanata, Chiara Simion, Carla Serra, Paolo Simioni, Fabio Piscaglia, Elena Campello and Walter Ageno
J. Clin. Med. 2024, 13(5), 1517; https://doi.org/10.3390/jcm13051517
Full text available online: https://www.mdpi.com/2077-0383/13/5/1517
5. “Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions”
by Pankaj Garg, Sulabh Singhal, Prakash Kulkarni, David Horne, Jyoti Malhotra, Ravi Salgia and Sharad S. Singhal
J. Clin. Med. 2024, 13(14), 4189; https://doi.org/10.3390/jcm13144189
Full text available online: https://www.mdpi.com/2077-0383/13/14/4189
6. “Pulmonary Function Tests: Easy Interpretation in Three Steps”
by Josuel Ora, Federica Maria Giorgino, Federica Roberta Bettin, Mariachiara Gabriele and Paola Rogliani
J. Clin. Med. 2024, 13(13), 3655; https://doi.org/10.3390/jcm13133655
Full text available online: https://www.mdpi.com/2077-0383/13/13/3655
7. “Enhancing Pulmonary Embolism Mortality Risk Stratification Using Machine Learning: The Role of the Neutrophil-to-Lymphocyte Ratio”
by Minodora Teodoru, Mihai Octavian Negrea, Andreea Cozgarea, Dragoș Cozma and Adrian Boicean
J. Clin. Med. 2024, 13(5), 1191; https://doi.org/10.3390/jcm13051191
Full text available online: https://www.mdpi.com/2077-0383/13/5/1191
8. “Tele-Monitoring Applications in Respiratory Allergy”
by Xenofon Aggelidis, Maria Kritikou, Michael Makris, Michael Miligkos, Niki Papapostolou, Nikolaos G. Papadopoulos and Paraskevi Xepapadaki
J. Clin. Med. 2024, 13(3), 898; https://doi.org/10.3390/jcm13030898
Full text available online: https://www.mdpi.com/2077-0383/13/3/898
9. “The Efficacy of Continuous Serratus Anterior and Erector Spinae Plane Blocks vs Intercostal Nerve Block in Uniportal-Vats Surgery: A Propensity-Matched Prospective Trial”
by Dania Nachira, Giovanni Punzo, Giuseppe Calabrese, Flaminio Sessa, Maria Teresa Congedo, Giovanna Beccia, Paola Aceto, Khrystyna Kuzmych, Chiara Cambise, Carolina Sassorossi et al.
J. Clin. Med. 2024, 13(2), 606; https://doi.org/10.3390/jcm13020606
Full text available online: https://www.mdpi.com/2077-0383/13/2/606
10. “The Impact of Antimicrobial Resistance in Cystic Fibrosis”
by Antonio Vitiello, Francesco Blasi, Michela Sabbatucci, Andrea Zovi, Francesco Miele, Annarita Ponzo, Roberto Langella and Mariarosaria Boccellino
J. Clin. Med. 2024, 13(6), 1711; https://doi.org/10.3390/jcm13061711
Full text available online: https://www.mdpi.com/2077-0383/13/6/1711
|
Special Issues |
|
|
“Lung Transplantation: Current Strategies and Future Directions” |
“Bronchoscopy and Interventional Pulmonology” |
 |
 |
|
“Thoracic Surgery: Updates and New Trends” |
“Update on Acute Severe Respiratory Infections: 2nd Edition” |
 |
 |
12 June 2025
International Albinism Awareness Day—“Demanding Our Rights: Protect Our Skin, Preserve Our Lives”, 13 June 2025
International Albinism Awareness Day 2025 underscores the urgent need for increased awareness, preventive care, and accessible healthcare for people with albinism. This year’s theme highlights the life-threatening impact of skin cancer among individuals with albinism and reinforces the importance of sun protection, early detection, and timely treatment.
Albinism is a rare, inherited genetic condition that affects the body’s ability to produce melanin, the pigment responsible for the color of our skin, hair, and eyes. People with albinism typically have very light skin and hair, alongside various vision impairments. While it is not contagious and does not affect intelligence, albinism is often misunderstood. This leads to stigmatization, discrimination, and even human rights violations in some regions where harmful myths persist.
Because they have little to no melanin, individuals with albinism are especially vulnerable to sun damage and face a significantly increased risk of developing skin cancer. Addressing this requires more than just clinical intervention—it calls for integrated healthcare policies and inclusive social systems that acknowledge both the medical and socio-political dimensions of the condition.
In recognition of this global observance, we invite you to explore a curated collection of articles and Special Issues from selected MDPI journals, including Biomedicines, Cancers, Children, Diagnostics, Genes, International Journal of Molecular Sciences, Journal of Clinical Medicine and Molecules. These open-access resources provide critical insights into the diagnosis, management, and complications of albinism, and promote cross-disciplinary collaboration between researchers, clinicians, and advocacy groups.
Together, through science, education, and empathy, we can foster a more inclusive world where people with albinism live free from discrimination and with access to the care they deserve.
 |
 |
 |
 |
 |
 |
|
 |
“Can a Portable Flash Visual Evoked Potential (VEP) Device Identify Chiasmal Decussation Anomalies in Albinism?”
by Eloise Keeling, Perry Carter, Abdi Malik Musa, Fatima Shawkat, Helena Lee and Jay E. Self
Diagnostics 2025, 15(11), 1395; https://doi.org/10.3390/diagnostics15111395
“Common Variants in the TYR Gene with Unclear Pathogenicity as the Cause of Oculocutaneous Albinism in a Cohort of Russian Patients”
by Olga Shchagina, Anna Stepanova, Polina Mishakova, Vitaliy Kadyshev, Nina Demina, Ludmila Bessonova, Sofya Ionova, Daria Guseva, Andrey Marakhonov, Rena Zinchenko et al.
Biomedicines 2024, 12(10), 2234; https://doi.org/10.3390/biomedicines12102234
“Functional Characterization of Splice Variants in the Diagnosis of Albinism”
by Modibo Diallo, Cécile Courdier, Elina Mercier, Angèle Sequeira, Alicia Defay-Stinat, Claudio Plaisant, Shahram Mesdaghi, Daniel Rigden, Sophie Javerzat, Eulalie Lasseaux et al.
Int. J. Mol. Sci. 2024, 25(16), 8657; https://doi.org/10.3390/ijms25168657
“Genetic Linkage between CAPN5 and TYR Variants in the Context of Albinism and Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy Absence: A Case Report”
by Mirjana Bjeloš, Ana Ćurić, Mladen Bušić, Benedict Rak and Biljana Kuzmanović Elabjer
Int. J. Mol. Sci. 2024, 25(12), 6442; https://doi.org/10.3390/ijms25126442
“Missing Heritability in Albinism: Deep Characterization of a Hungarian Albinism Cohort Raises the Possibility of the Digenic Genetic Background of the Disease”
by Nikoletta Nagy, Margit Pal, Jozsef Kun, Bence Galik, Peter Urban, Marta Medvecz, Beata Fabos, Alexandra Neller, Aliasgari Abdolreza, Judit Danis, Viktoria Szabo, Zhuo Yang, Stefanie Fenske, Martin Biel, Attila Gyenesei, Eva Adam and Marta Szell
Int. J. Mol. Sci. 2024, 25(2), 1271; https://doi.org/10.3390/ijms25021271
“Does Foveal Hypoplasia Affect Emmetropization in Patients with Albinism?”
by Line Kessel, Christine Dahlgren Bohnsack Kjølholm and Joaquim Torner Jordana
Children 2023, 10(12), 1910; https://doi.org/10.3390/children10121910
“Vision-Related Quality of Life in Danish Patients with Albinism and the Impact of an Updated Optical Rehabilitation”
by Kristian Lisbjerg, Joaquim Torner Jordana, Vibeke N. Brandt, Christine Kjølholm and Line Kessel
J. Clin. Med. 2023, 12(17), 5451; https://doi.org/10.3390/jcm12175451
“Skin Pigmentation Types, Causes and Treatment—A Review”
by Amin Mahmood Thawabteh, Alaa Jibreen, Donia Karaman, Alà Thawabteh and Rafik Karaman
Molecules 2023, 28(12), 4839; https://doi.org/10.3390/molecules28124839
“Report of Hermansky–Pudlak Syndrome in Two Families with Novel Variants in HPS3 and HPS4 Genes”
by Sadeeda Qaiser Zaman, Muhammad Anas, Gauhar Rehman, Qadeem Khan, Aiman Iftikhar, Mashal Ahmad, Muhammad Owais, Ilyas Ahmad, Osama Yousef Muthaffar, Angham Abdulrhman Abdulkareem et al.
Genes 2023, 14(1), 145; https://doi.org/10.3390/genes14010145
“Diagnostic Yield of Genetic Testing for Ocular and Oculocutaneous Albinism in a Diverse United States Pediatric Population”
by Kyle S. Chan, Brenda L. Bohnsack, Alexander Ing, Andy Drackley, Valerie Castelluccio, Kevin X. Zhang, Hanta Ralay-Ranaivo and Jennifer L. Rossen
Genes 2023, 14(1), 135; https://doi.org/10.3390/genes14010135
| “More than Skin Deep—Latest Advances in Congenital and Autoimmune Pigmentation Disorders” Guest Editor: Prof. Dr. Reinhart M. Speeckaert Submission deadline: 25 August 2025 |
“Melanin Pigmentation: Physiology and Pathology” Guest Editors: Prof. Dr. Shosuke Ito and Prof. Dr. Manickam Sugumaran Submission deadline: 20 October 2025 |
 |
 |
10 June 2025
Journal of Clinical Medicine | Highly Cited Papers Published in 2024 and Hot Topic Special Issues in the “Ophthalmology” Section
To date, 2064 papers have been published in the “Ophthalmology” Section of Journal of Clinical Medicine (JCM, ISSN: 2077-0383). You are welcome to read the 2024 highly cited papers and find the latest publications through the following link: https://www.mdpi.com/search?journal=jcm§ion=501.
Our “Ophthalmology” Section’s subject areas, including but not limited to the following:- Ophthalmology and eye disease;
- Diagnosis, epidemiology, treatment, and management of ophthalmic disorders/conditions, Innovative approaches for analytics;
- Novel imaging of disease biomarkers;
- Genomics and bioinformatics related to clinical or pre-clinical research, and clinical studies that elucidate eye disease mechanisms;
- Novel therapies for blinding disorders;
- Clinical practice of telemedicine in ophthalmology;
- Vulnerable populations and ophthalmic disease disparities;
- Co-segregating diseases, with examples including disease protection, therapy resistance, disease progression, and disease severity.
Some Special Issues in the “Ophthalmology” Section are currently open for submissions. The following is a list of articles and Special Issues that we believe may interest you:
1. “Efficacy and Safety of Low-Dose Atropine on Myopia Prevention in Premyopic Children: Systematic Review and Meta-Analysis”
by Ssu-Hsien Lee, Bor-Yuan Tseng, Jen-Hung Wang and Cheng-Jen Chiu
J. Clin. Med. 2024, 13(5), 1506; https://doi.org/10.3390/jcm13051506
Full text available online: https://www.mdpi.com/2077-0383/13/5/1506
2. “Impact of Brightness on Choroidal Vascularity Index”
by Nicola Rosa, Marco Gioia, Rachele Orlando, Martina De Luca, Eleonora D’Aniello, Isabella Fioretto, Ciro Sannino and Maddalena De Bernardo
J. Clin. Med. 2024, 13(4), 1020; https://doi.org/10.3390/jcm13041020
Full text available online: https://www.mdpi.com/2077-0383/13/4/1020
3. “Optic Nerve Neuroprotection in Glaucoma: A Narrative Review”
by Angela D’Angelo, Livio Vitiello, Filippo Lixi, Giulia Abbinante, Alessia Coppola, Vincenzo Gagliardi, Alfonso Pellegrino and Giuseppe Giannaccare
J. Clin. Med. 2024, 13(8), 2214; https://doi.org/10.3390/jcm13082214
Full text available online: https://www.mdpi.com/2077-0383/13/8/2214
4. “The Treatment of Diabetic Retinal Edema with Intravitreal Steroids: How and When”
by Maria Letizia Salvetat, Francesco Pellegrini, Leopoldo Spadea, Carlo Salati, Mutali Musa, Caterina Gagliano and Marco Zeppieri
J. Clin. Med. 2024, 13(5), 1327; https://doi.org/10.3390/jcm13051327
Full text available online: https://www.mdpi.com/2077-0383/13/5/1327
5. “Myopia Is an Ischemic Eye Condition: A Review from the Perspective of Choroidal Blood Flow”
by Baksh, Jiaul, Deokho Lee, Kiwako Mori, Yan Zhang, Hidemasa Torii, Heonuk Jeong, Jing Hou, Kazuno Negishi, Kazuo Tsubota and Toshihide Kurihara
J. Clin. Med. 2024, 13(10), 2777; https://doi.org/10.3390/jcm13102777
Full text available online: https://www.mdpi.com/2077-0383/13/10/2777
6. “Summary of the Therapeutic Options for Patients with Dry and Neovascular AMD”
by Dorota Śpiewak, Łukasz Drzyzga, Mariola Dorecka and Dorota Wyględowska-Promieńska
J. Clin. Med. 2024, 13(14), 4227; https://doi.org/10.3390/jcm13144227
Full text available online: https://www.mdpi.com/2077-0383/13/14/4227
7. “Drusen in AMD from the Perspective of Cholesterol Metabolism and Hypoxic Response”
by Norimitsu Ban, Ari Shinojima, Kazuno Negishi and Toshihide Kurihara
J. Clin. Med. 2024, 13(9), 2608; https://doi.org/10.3390/jcm13092608
Full text available online: https://www.mdpi.com/2077-0383/13/9/2608
8. “Unveiling Ocular Manifestations in Systemic Lupus Erythematosus”
by Mutali Musa, Ekele Chukwuyem, Oluwasola Michael Ojo, Efioshiomoshi Kings Topah, Leopoldo Spadea, Carlo Salati, Caterina Gagliano and Marco Zeppieri
J. Clin. Med. 2024, 13(4), 1047; https://doi.org/10.3390/jcm13041047
Full text available online: https://www.mdpi.com/2077-0383/13/4/1047
9. “From Clinical Suspicion to Diagnosis: A Review of Diagnostic Approaches and Challenges in Fungal Keratitis”
by Panagiotis Toumasis, Andreas G. Tsantes, Anastasia Tsiogka, George Samonis and Georgia Vrioni
J. Clin. Med. 2024, 13(1), 286; https://doi.org/10.3390/jcm13010286
Full text available online: https://www.mdpi.com/2077-0383/13/1/286
10. “Biomimetic Curcumin-Loaded Liposomes for the Treatment of Dry Eyes and Meibomian Gland Dysfunction: An In Vivo Study”
by Vytautas Baranauskas, Ruta Jaruseviciene, Mantas Grigalavicius, Saulius Galgauskas, Vitalijus Karabanovas and Simona Steponkiene
J. Clin. Med. 2024, 13(21), 6436; https://doi.org/10.3390/jcm13216436
Full text available online: https://www.mdpi.com/2077-0383/13/21/6436
|
Special Issues: |
|
|
“Cataract and Refractive Surgery and Intraocular Lens Implantation: Clinical Advances and Perspectives” |
“Innovations in the Clinical Management of Retinal Diseases: Emerging Therapies and Visual Rehabilitation” |
 |
 |
|
|
“Clinical Challenges and Advances in Dry Eye Disease and Meibomian Gland Dysfunction” |
 |
 |
4 June 2025
Journal of Clinical Medicine | Notable Papers in Q1 of 2025
